Blueberry Therapeutics Limited would like to announce that it has completed a £3.6m extension to the previously successful Series B [...]
Susan Yau2021-01-29T17:40:20+00:00January 29th, 2021|
A Blueberry case study
In this video, Blueberry Therapeutics CEO John Ridden and CSO David Cook talk about the early days of Blueberry Therapeutics, the short term and long term plans for the company, and the benefits of being based at Alderley Park, Cheshire.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.